Home Blog Page 485

Global Customers Are Taking a Closer Look at Focused Photonics Inc.

HANGZHOU, China, April 27, 2026 /PRNewswire/ — For scientific instrument companies competing globally, differentiation increasingly depends on more than product specifications alone. Customers are looking beyond performance claims to assess whether a company can consistently translate technology into manufacturable products, proven applications, reliable delivery and long-term service support.

That shift was evident during Focused Photonics Inc.’s (FPI) Global Customer Experience Day 2026 in Hangzhou, where customers and partners from dozens of countries visited the company’s Qingshanhu Innovation Base, headquarters and live application sites. For many attendees, the event offered a closer look at how a China-headquartered scientific instrument company is building capabilities across R&D, manufacturing, systems integration and lifecycle support.

At Qingshanhu Innovation Base, visitors saw key stages of FPI’s operations firsthand, including engineering, precision manufacturing, system integration, testing and service readiness. For many international customers, these visits are less about viewing a production line and more about assessing execution: whether a supplier has the engineering discipline, manufacturing depth and support infrastructure required to deliver consistently in real operating environments.

This is becoming increasingly important across the industry. As customer expectations evolve, competition is moving beyond stand-alone instrument performance toward integrated solutions, automation, data integrity, compliance and lifecycle value. In industrial and environmental applications in particular, uptime, stability and workflow fit often matter as much as analytical capability.

At its global customer conference, FPI outlined how it is responding to that transition, highlighting continued investment across environmental monitoring, industrial process analysis, laboratory analysis and life science applications. The company is also expanding the role of digitalization, automation and AI to improve application readiness and solution delivery.

Application-focused exchanges during the event reinforced the same point. In discussions on environmental, industrial and laboratory scenarios, customers focused not only on performance metrics, but also on regulatory fit, workflow integration, long-term operation under complex conditions, and the ability of solutions to function reliably once deployed. These are increasingly central criteria in global purchasing decisions.

The clearest proof came from real-world settings. At the Hangzhou Ecological Environment Monitoring Center, visitors saw FPI’s automated water quality laboratory in operation, where sample handling, workflow continuity and data generation are integrated into day-to-day use. For customers, this offered a more concrete view of how a solution performs not just in demonstration, but in routine operation.

Taken together, the event underscored a broader industry reality: global competition in scientific instruments is increasingly defined not only by what a product can do, but by whether a company can manufacture it at scale, deploy it effectively, support it locally and sustain performance over time. That broader operational capability is becoming a decisive part of how international customers evaluate suppliers.

Aqount Technologies: Most SMEs Use Accounting Software But Still Lack Financial Clarity

Aqount Technologies launches Financial Clarity Check to help SMEs fix structural accounting issues masking true business performance.


KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 27 April 2026 – Aqount Technologies, a specialist in comprehensive accounting and bookkeeping services, today announced the launch of Financial Clarity Check. This new, free tool is designed to help small and medium-sized enterprises (SMEs) bridge the gap between simple bookkeeping and powerful decision-making by identifying deep-seated structural accounting issues that often mask true business performance.

Aqount Technologies launches Financial Clarity Check to help SMEs fix structural accounting issues masking true business performance.
Aqount Technologies launches Financial Clarity Check to help SMEs fix structural accounting issues masking true business performance.

The launch comes at a critical time for businesses across Southeast Asia. While thousands of SMEs have adopted cloud platforms like Xero to automate invoicing and reporting, Aqount Technologies has observed that software alone does not guarantee financial clarity. Despite these digital advances, many founders still struggle to determine if they are truly profitable, why cash flow remains tight, or which business segments drive the strongest margins.

The Hidden Problem: Structure, Not Software

Cloud accounting platforms are powerful, but they are only as useful as the structure behind them. When financial data is poorly organised, even well-implemented systems can become record-keeping tools rather than decision-making tools.

Finance professionals working with SMEs frequently observe a similar pattern. Profits may appear healthy while cash flow remains constrained, expenses are often grouped too broadly to analyse, and key cost drivers remain hidden within generic categories. Reports may be technically correct, yet difficult for founders to interpret or act upon.

In such cases, the issue is not the software itself, but how the accounting system has been structured and maintained over time.

Why Financial Clarity Breaks Down as Businesses Grow

Most SMEs set up their accounting systems quickly in the early stages, focusing on compliance and basic record-keeping. As the business grows, new revenue streams are added, cost structures become more complex, and different team members begin recording transactions in varying ways.

Over time, the system can become fragmented. The result is a business that contains a large volume of financial data, but lacks the structure needed to generate meaningful insight.

What Financial Diagnostics Typically Reveal

When accounting systems are reviewed at a structural level, several recurring issues often emerge. Expenses are frequently misclassified, leading to distorted profitability. Profit margins may be overstated due to incomplete cost allocation. Key cost drivers are buried within broad categories, and financial reports do not reflect how the business actually operates.

These issues are rarely visible at first glance, but they can have a material impact on decision-making.

A Real Example: When ‘Profitable’ Didn’t Mean Profitable

In one case, a Southeast Asian SME in a service-based industry appeared to be performing well on paper. Revenue was growing steadily, and monthly reports showed consistent profitability. The business was using cloud accounting software and maintaining regular bookkeeping.

Yet cash flow remained persistently tight. A financial review of the accounting structure revealed that operational costs were grouped too broadly, masking true cost drivers. Certain expenses had been misclassified, overstating profitability, and costs were not properly attributed to specific services.

After restructuring the chart of accounts and improving cost categorisation, previously ‘profitable’ services were found to be operating at thin or negative margins. At the same time, higher-performing segments became clearly identifiable, enabling management to make more informed pricing and cost decisions.

Within a short period, the business gained significantly clearer visibility into its financial performance, not by changing the software, but by improving the structure behind it.

From Bookkeeping to Decision-Making

When properly structured, accounting systems can serve as operational dashboards rather than simple record-keeping tools. They allow business leaders to understand which products or services generate the strongest margins, track cost trends over time, identify inefficiencies early, and make decisions with greater confidence.

For businesses with more complex operations, this level of financial visibility is increasingly essential.

Assessing Financial Clarity

For SMEs already using platforms such as Xero, the next step is not adopting additional tools, but ensuring that the accounting system is structured effectively. Aqount has developed a Financial Clarity Check designed to evaluate key aspects of an accounting system, including chart-of-accounts design, categorisation consistency, reporting clarity, and overall system health.

Businesses can access the Financial Clarity Check at https://clarity.aqount.tech. The process takes only a few minutes and provides an initial indication of whether an accounting system is supporting effective decision-making.

Hashtag: #Fintech #SMEs #SoutheastAsia #Accounting #FinancialClarity #CloudAccounting #Aqount


The issuer is solely responsible for the content of this announcement.

About Aqount Technologies

Aqount Technologies specializes in comprehensive accounting and bookkeeping services, providing businesses with accurate insights for strategic decision-making.

At Aqount Technologies, we go beyond numbers. We cultivate lasting relationships, tailoring our services to your specific financial goals. Our expert team ensures compliance, security, and industry-specific expertise, giving you the confidence to navigate your financial landscape.

Our services include accounting & financial reporting, bookkeeping & recordkeeping, tax planning & compliance, payroll processing, financial analysis & forecasting, and audit preparation & support.

Experience a seamless financial journey with Aqount Technologies and join us in achieving excellence in your business’s financial strategy.

Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes

– 13-week U.S. Phase II study is evaluating the efficacy, safety and tolerability of oral small molecule GLP-1R agonist ASC30, a once-daily tablet, in 100 participants with diabetes.

– Topline data from the Phase II study are expected in the third quarter of 2026.

HONG KONG, April 27, 2026 /PRNewswire/ — Ascletis Pharma Inc. (HKEX: 1672, “Ascletis”) announces today completion of enrollment in its 13-week U.S. Phase II study (NCT07321678) evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist, for the treatment of type 2 diabetes mellitus (T2D). T2D is the second indication for ASC30, following its first indication of obesity. Topline data from the Phase II study for the treatment of T2D are expected in the third quarter of 2026.

“ASC30 has potential to be the best-in-class oral small molecule GLP-1 for obesity, evidenced by its efficacy and tolerability demonstrated by the U.S. Phase II study in participants with obesity or overweight,” said Jinzi Jason Wu, Ph.D., Founder, Chairman and CEO of Ascletis, “Expanding ASC30’s clinical development into the large diabetes treatment market is a logical next step that provides us with another chance to highlight ASC30’s potential best-in-class profile as a once-daily oral treatment option for patients. We look forward to sharing topline data from the Phase II study in diabetes participants in the third quarter of 2026.”

Dr. Wu added, “Based on the positive clinical results announced in December 2025 from our 13-week U.S. Phase II study of ASC30 in participants with obesity or overweight, the Company expects to obtain the clearance from the U.S. Food and Drug Administration and initiate Phase III trials in the U.S. for obesity indication by the end of the third quarter 2026.”

ASC30 was discovered and developed in-house at Ascletis as a first and only investigational small molecule GLP-1R fully biased agonist that can be dosed once daily orally and once monthly to once quarterly subcutaneously for the treatment of obesity, diabetes and other metabolic diseases.

About the U.S. Phase II Study with ASC30 for the Treatment of Diabetes

The Phase II study is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate the efficacy, safety, and tolerability of ASC30 tablets in participants with type 2 diabetes mellitus. The primary endpoint of the Phase II study is the mean change from baseline in HbA1c up to 13 weeks in the treatment group compared with the placebo group. Secondary endpoints include the mean change from baseline in fasting blood glucose up to 13 weeks in the treatment group compared with the placebo group, the mean change from baseline in body weight up to 13 weeks in the treatment group compared with placebo group, and safety and tolerability. The Phase II study enrolled 100 participants with type 2 diabetes mellitus at multiple sites across the U.S. Participants were randomly assigned in a ratio of approximately 2:3:3:2 to 40 mg, 60 mg and 80 mg ASC30 tablets and matching placebo tablets, respectively. ASC30 was titrated weekly from 1 mg to target doses of 40 mg, 60 mg and 80 mg.

About Ascletis Pharma Inc.

Ascletis Pharma Inc. is a fully integrated biotechnology company focused on the development and commercialization of potential best-in-class and first-in-class therapeutics to treat metabolic diseases. Utilizing its proprietary Artificial Intelligence-assisted Structure-Based Drug Discovery (AISBDD) and Ultra-Long-Acting Platform (ULAP) technologies as well as Peptide Oral Transport ENhancement Technology (POTENT), Ascletis has developed multiple drug candidates in-house, including both small molecules and peptides, such as its lead program, ASC30, a small molecule GLP-1R agonist designed to be administered once daily orally and once monthly to once quarterly subcutaneously as a treatment therapy and a maintenance therapy for chronic weight management; ASC36, an amylin receptor peptide agonist, ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist and ASC37, a GLP-1R/GIPR/GCGR triple peptide agonist, ASC39, a potent and amylin-selective oral small molecule amylin receptor agonist, and ASC30_39 FDC, a fixed-dose combination (FDC) of ASC30 and ASC39, for chronic weight management. Ascletis is listed on the Hong Kong Stock Exchange (1672.HK).

For more information, please visit www.ascletis.com.

Contact:

Peter Vozzo
ICR Healthcare
443-231-0505 (U.S.)
Peter.vozzo@icrhealthcare.com

Ascletis Pharma Inc. PR and IR Teams
+86-181-0650-9129 (China)
pr@ascletis.com
ir@ascletis.com 

HD Hyundai Heavy Industries Wins South Korea’s First Overseas Icebreaker Order

  • Signed a $348.9 million contract with the Swedish Maritime Administration for one icebreaker, to be delivered in 2029
  • Won the order over leading icebreaker builders, including Finland and Norway
  • “We plan to expand new export markets in the special-purpose ship sector based on our technological capabilities and integrated business expertise.”

SEOUL, South Korea, April 27, 2026 /PRNewswire/ — HD Hyundai Heavy Industries has become the first Korean shipbuilder to secure an overseas order for a dedicated icebreaker.

(From the left) Lee Hyung-jong, Ambassador of the Republic of Korea to the Kingdom of Sweden, Joo Won-ho, President and CEO of HD Hyundai Heavy Industries, Erik Eklund, Director General of the Swedish Maritime Administration, Andreas Carlson, Minister for Infrastructure and Housing of Sweden, at the contract signing ceremony of the construction and delivery of a new icebreaker.
(From the left) Lee Hyung-jong, Ambassador of the Republic of Korea to the Kingdom of Sweden, Joo Won-ho, President and CEO of HD Hyundai Heavy Industries, Erik Eklund, Director General of the Swedish Maritime Administration, Andreas Carlson, Minister for Infrastructure and Housing of Sweden, at the contract signing ceremony of the construction and delivery of a new icebreaker.

The company said it has signed a $348.9 million contract with the Swedish Maritime Administration to build one icebreaker.

In the bidding process, HD Hyundai Heavy Industries received strong, well-rounded evaluations for price competitiveness, delivery schedules and technological capabilities. The icebreaker under this contract is scheduled for delivery in 2029 and will provide icebreaking support, fleet operations, towing services and ice management in the Baltic Sea off Sweden.

This order was secured amid growing global attention on Arctic shipping routes and Arctic Ocean exploration, after competing with leading icebreaker builders, including Finland and Norway. It is significant as it marks the first time a South Korean shipbuilder has entered the global icebreaker market.

The deal was also the result of strong public-private cooperation, with active support from the Embassy of the Republic of Korea in Sweden and the KOTRA Stockholm Trade Office.

An icebreaker is a specialized ship designed to navigate ice-covered seas by breaking sea ice to open navigable routes. It features a reinforced hull, strong icebreaking capability and a specially designed hull form that allows it to push through and clear ice.

The icebreaker ordered by Sweden from HD Hyundai Heavy Industries will measure 126 meters in length and have a displacement of about 15,000 tons. It will feature Polar Class 4 (PC4) icebreaking capability and an electric propulsion system. PC4 generally refers to the ability to continuously break ice approximately 1 to 1.2 meters thick.

The United States has also significantly expanded its investment in icebreaker capabilities, passing legislation last year that increased related funding to about $9 billion. It has also formed the “ICE (Icebreaker Collaboration Effort) Pact” in cooperation with Canada and Finland as part of broader efforts to strengthen polar maritime operations.

According to the ICE Pact, the partners aim to build 70 to 90 icebreakers over the next 10 years.

HD Hyundai Heavy Industries aims to actively expand into the global naval and special-purpose vessel markets that require icebreaking capability, leveraging its proven expertise in building icebreakers.

“Following this icebreaker order, global recognition has been given to the strengthened business capabilities achieved through the integration of HD Hyundai Heavy Industries and HD Hyundai Mipo. We will continue to expand new export markets in the special-purpose ship segment based on our technological capabilities and integrated business expertise,” said Joo Won-ho, Head of HD Hyundai Heavy Industries’ Naval and Medium Ship Business.

iMarketKorea Signs Two MOUs with Vietnam’s Phu Tho Provincial People’s Committee and BIDV

Participates in Korea-Vietnam Economic Delegation

  • Accelerates development of an industrial park in Phu Tho Province near Hanoi, while attracting advanced manufacturing companies and building a supply chain ecosystem
  • Plans parallel development of an Inland Container Depot (ICD) to strengthen logistics competitiveness
  • Expands discussions with Bank for Investment and Development of Vietnam (BIDV) on financial support measures and new business opportunities

HANOI, Vietnam and SEOUL, South Korea, April 27, 2026 /PRNewswire/ — iMarketKorea, a leading industrial materials distribution company led by CEO Kim Hak-jae, announced that it has signed two Memoranda of Understanding (MOUs) with the Phu Tho Provincial People’s Committee and Bank for Investment and Development of Vietnam during the MOU signing session at the Korea-Vietnam Business Forum, hosted by Korea’s Ministry of Trade, Industry and Energy and the Korea Chamber of Commerce and Industry. The company participated in the official Korea-Vietnam economic delegation.

iMarketKorea participated in the “Korea-Vietnam Business Forum” held in Hanoi, Vietnam, on April 23, where it signed a memorandum of understanding with the People’s Committee of Phu Tho Province, Vietnam, for cooperation on an industrial complex development project. Pictured from left: Kim Hak-jae, Tran Duy Dong, Kim Jung-kwan, and Ngo Van Tuan.
iMarketKorea participated in the “Korea-Vietnam Business Forum” held in Hanoi, Vietnam, on April 23, where it signed a memorandum of understanding with the People’s Committee of Phu Tho Province, Vietnam, for cooperation on an industrial complex development project. Pictured from left: Kim Hak-jae, Tran Duy Dong, Kim Jung-kwan, and Ngo Van Tuan.

As Vietnam’s investment environment continues to advance, cooperation in production infrastructure such as industrial parks has become increasingly important. Based on prior discussions with Phu Tho Province, iMarketKorea formalized this partnership through the latest agreements.

Located near Noi Bai International Airport, Phu Tho Province is emerging as a strategic logistics hub and an attractive production base for global companies. The province recorded 10.52% gross regional domestic product (GRDP) growth in 2025, ranking fourth among Vietnam’s provinces.

Through the agreement, iMarketKorea plans to develop a national industrial park in Phu Tho Province and actively attract global manufacturing companies. The company also aims to build a supply chain-driven industrial ecosystem by strengthening collaboration among related businesses centered around the industrial complex.

To enhance logistics competitiveness, iMarketKorea will also pursue the development of an Inland Container Depot (ICD) with bonded warehousing functions. An ICD is an inland logistics hub enabling customs clearance and cargo handling. When integrated with the industrial park, it is expected to improve import-export efficiency and strengthen the region’s attractiveness to manufacturers.

Kim Hak-jae, CEO of iMarketKorea, said, “This agreement establishes the foundation for integrated production and logistics infrastructure. Through cooperation with the Phu Tho provincial government and BIDV, we plan to establish a one-stop support system covering administration, finance, legal matters, and taxation. We will also create an environment where high-tech parts and materials companies can effectively utilize local incentives and gradually expand future cooperation.”

Elliott Management Releases Presentation on Daikin Industries, Ltd.

LONDON, April 27, 2026 /PRNewswire/ — Elliott Investment Management L.P. and Elliott Advisors (UK) Limited (“Elliott”), which advise funds that together own approximately 3% of Daikin Industries, Ltd. (“Daikin” or the “Company”), today released an investor presentation titled “Elliott’s Perspectives on Daikin.”

In the presentation, Elliott outlined the significant opportunity for Daikin to increase its profitability, improve its capital efficiency and drive a higher valuation for its shares by taking bold steps to close its margin gap versus its peers, launch an ambitious share repurchase program and conduct a strategic review of its non-core businesses. The presentation described a credible pathway for Daikin to achieve a 14% operating profit margin which, combined with targeted share repurchases, could see the Company’s earnings per share more than double.  

Elliott remains committed to working constructively with Daikin to deliver an ambitious, credible medium-term management plan that helps the Company close the performance and valuation gaps to its peers.

The presentation can be viewed at https://elliottletters.com.

About Elliott

Elliott Investment Management L.P. (together with its affiliates, “Elliott”) manages approximately $79.8 billion of assets as of December 31, 2025. Founded in 1977, it is one of the oldest funds under continuous management. The Elliott funds’ investors include pension plans, sovereign wealth funds, endowments, foundations, funds-of-funds, high net worth individuals and families, and employees of the firm. Elliott Advisors (UK) Limited is an affiliate of Elliott Investment Management L.P.

Media Contacts:

London
Stijn van de Grampel
Elliott Advisors (UK) Limited
T: +44 20 3009 1061
svdgrampel@elliottadvisors.co.uk

New York
Stephen Spruiell
Elliott Investment Management L.P.
T: +1 (212) 478-2017
sspruiell@elliottmgmt.com

Tokyo
Brett Wallbutton
Ashton Consulting
T: +81 (0) 3 5425-7220
b.wallbutton@ashton.jp

GLN Connects to Vietnam’s National QR Network, Enabling Nationwide QR Payments

  • Direct access to Vietnam’s nationwide QR payment network
  • Enabling payments via partners’ home-market banking and fintech apps without currency exchange

SEOUL, South Korea, April 27, 2026 /PRNewswire/ — GLN International has launched a nationwide QR payment service in Vietnam in partnership with NAPAS, marking its direct integration into the country’s national QR payment infrastructure.

At the Vietnam QR payment service launch ceremony
At the Vietnam QR payment service launch ceremony

The service was introduced at a launch ceremony on April 23 in Vietnam, attended by the State Bank of Vietnam (SBV), NAPAS, BIDV, and Hana Bank.

GLN leads the operation of the payment system connected to Vietnam’s national QR network and has driven its technical integration, as part of Hana Financial Group’s cross-border initiatives. Hana Bank participates as the only Korean financial institution designated as a settlement bank under SBV approval.

Vietnam’s payment infrastructure is built on the VietQR Global system operated by NAPAS, linking banks and merchants nationwide. Through this integration, GLN enables users of partner apps to access the network, expanding acceptance. The partnership is also expected to support inbound use cases, allowing Vietnamese users to make QR payments in Korea via their local apps.

The service is available across tourist destinations, including Da Nang, Phu Quoc, Nha Trang, and Ho Chi Minh City, across everyday merchants. Payments can be made through GLN-connected partner applications, including major Korean fintech apps such as Toss, PurpleGLN, Hana OneQ, Hana Money, and Hana Card, without currency exchange. The service is expected to expand to platforms, including Naver Pay and KB Banking App.

Image of supported apps and QR logos enabling nationwide QR payments across Vietnam
Image of supported apps and QR logos enabling nationwide QR payments across Vietnam

Seok Lee, CEO of GLN, said, “This launch marks a significant step in connecting Korea and Vietnam through a unified QR payment infrastructure. By integrating with Vietnam’s national QR network, we enable a simple payment experience for travelers using the apps they already use in their home market, without currency exchange. We will continue to lead overseas payments and cash withdrawals without physical cards.”

Meanwhile, GLN, a subsidiary of Hana Bank under Hana Financial Group, provides QR payment and QR withdrawal services across 14 countries in Asia, including Vietnam, China, Thailand, the Philippines, Laos, and Japan, with access to more than 200 million QR merchants globally. The company is a leading cross-border payment infrastructure provider in Asia, connecting users and merchants across markets. It has also established partnerships with overseas financial platforms, including Moreta Pay (North America), DeCard App (Singapore), and Taishin Bank (Taiwan).

 

VARON Celebrates 5 Years Supporting Easier Breathing for Customers Worldwide

NEW YORK, April 27, 2026 /PRNewswire/ — VARON is celebrating a meaningful milestone, its 5th anniversary, and is taking this moment to thank customers around the world who have trusted its oxygen therapy solutions over the years. What started as a mission to make breathing support more accessible has grown into a global community of users relying on VARON’s advanced oxygen machines in their daily lives.

This anniversary is not just about the company’s growth, but about the people behind it—the individuals and families who have chosen VARON for comfort, independence, and peace of mind.

Five Years of Supporting Easier Breathing and Everyday Living

Over the past five years, VARON has focused on one simple idea: making oxygen therapy easier to use, easier to move with, and easier to trust. From home use to travel needs, the brand has continued improving its range of oxygen machines to support different lifestyles and health needs.

Today, VARON offers a full lineup that includes compact portable oxygen concentrator models and reliable at home oxygen concentrator systems designed for long-term use. Many users also prefer VARON’s lightweight oxygen concentrator options, which allow more freedom of movement without sacrificing performance.

“Our customers are at the center of everything we do,” VARON CEO shared in a message marking the anniversary. “We are deeply grateful for the trust placed in us over the past five years. Every device we create is built with real people and real daily needs in mind.”

Designed for Real Life: Home and On-the-Go Oxygen Support

VARON’s oxygen solutions are designed to fit into everyday routines—whether at home, during travel, or while staying active.

At home users continue to rely on models like the Serene 5 Home Oxygen Concentrator, which delivers steady medical-grade oxygen with quiet operation and simple controls. The Serene 3 offers a compact option for those who want efficient oxygen support in a smaller footprint.

For users needing flexibility, the VH-2 Pro Home Oxygen Concentrator provides adjustable flow settings and added features like nebulization support, making it a practical choice for daily home use.

On the portable side, VARON continues to expand independence for users who need oxygen on the move. The VP-8G Ultra Portable Oxygen Concentrator stands out for its ultra-lightweight design at just 4.37 lbs, making it easy to carry while traveling or running errands. The VP-6 Continuous Portable Oxygen Concentrator and VP-2 Portable Oxygen Concentrator offer additional options with adjustable flow settings and dependable oxygen delivery.

Each portable oxygen concentrator is designed with user comfort in mind—lightweight, easy to operate, and built for mobility without stress.

A Simple Way to Say Thank You: Anniversary Discounts and Free Gifts

To celebrate its 5th year, VARON is launching a limited-time global appreciation event with special savings across its entire product range.

Customers can enjoy featured anniversary offers:

  • 18% OFF sitewide across all oxygen machines
  • Free VARON gifts, including a $30 store gift card and extra nasal cannulas with every machine purchase
  • Up to 40% OFF selected featured products
  • Automatic discounts applied at checkout—no codes needed

Customers can also save more with bundle options such as the VP-8G Super Bundle and extra battery packages for VP-6 and VP-2 models.

“These anniversary offers are our way of saying thank you,” VARON CEO shared. “We want to make it easier for more people to access reliable oxygen support at home and on the go.”

Looking Ahead with Customers at the Center

As VARON moves into its sixth year, the company remains focused on improving its oxygen therapy technology and expanding accessibility worldwide. Future development will continue to focus on making portable oxygen concentrator devices lighter, more efficient, and easier to use in everyday life.

The goal remains simple: to help more people breathe easier and live with greater confidence and independence.

About VARON

VARON is a trusted provider of oxygen therapy solutions, offering a wide range of at home oxygen concentrator systems, portable oxygen concentrator devices, and advanced oxygen machines designed for home, travel, and personal use. The company is committed to creating lightweight oxygen concentrator technology that supports comfort, mobility, and better quality of life.

For more information on VARON’s 5th anniversary offers and full product lineup, customers are encouraged to visit the official VARON website.

Media Contact:
VARON Oxygen Concentrator
Email: support@varoninc.com
Website: https://varoninc.com/